Clinical Trial Testing Effectiveness of Blood Cancer Drug in Recurrent Glioblastoma
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).